Medical Care
Global Cardiovascular Diseases Stem Cell Therapy Market Research Report 2025
- Jan 16, 26
- ID: 675214
- Pages: 90
- Figures: 90
- Views: 6
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Diseases Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Diseases Stem Cell Therapy.
The Cardiovascular Diseases Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular Diseases Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular Diseases Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pharmicell
Gencell
BlueRock Therapeutics
Cellino Biotech
Mesoblast
BioCardia
Cedars-Sinai
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell
Heartseed
EmCell
Segment by Type
Autologous
Allogeneic
Segment by Application
Preclinical
Clinical Phase 1,2
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Diseases Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cardiovascular Diseases Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular Diseases Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular Diseases Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pharmicell
Gencell
BlueRock Therapeutics
Cellino Biotech
Mesoblast
BioCardia
Cedars-Sinai
Stem Cells Transplant Institute
CCTRN
Help Therapeutics Co., Ltd.
Beijing Cellapy biotechnology Co., LTD
CardioCell
Heartseed
EmCell
Segment by Type
Autologous
Allogeneic
Segment by Application
Preclinical
Clinical Phase 1,2
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Diseases Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Cardiovascular Diseases Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Cardiovascular Diseases Stem Cell Therapy Growth Trends by Region
2.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Cardiovascular Diseases Stem Cell Therapy Market Dynamics
2.3.1 Cardiovascular Diseases Stem Cell Therapy Industry Trends
2.3.2 Cardiovascular Diseases Stem Cell Therapy Market Drivers
2.3.3 Cardiovascular Diseases Stem Cell Therapy Market Challenges
2.3.4 Cardiovascular Diseases Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue
3.1.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Cardiovascular Diseases Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cardiovascular Diseases Stem Cell Therapy Revenue
3.4 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Diseases Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Cardiovascular Diseases Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Product and Application
3.7 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Type
4.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Application
5.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
6.2 North America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmicell
11.1.1 Pharmicell Company Details
11.1.2 Pharmicell Business Overview
11.1.3 Pharmicell Cardiovascular Diseases Stem Cell Therapy Introduction
11.1.4 Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.1.5 Pharmicell Recent Development
11.2 Gencell
11.2.1 Gencell Company Details
11.2.2 Gencell Business Overview
11.2.3 Gencell Cardiovascular Diseases Stem Cell Therapy Introduction
11.2.4 Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.2.5 Gencell Recent Development
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Details
11.3.2 BlueRock Therapeutics Business Overview
11.3.3 BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Introduction
11.3.4 BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.3.5 BlueRock Therapeutics Recent Development
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Details
11.4.2 Cellino Biotech Business Overview
11.4.3 Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Introduction
11.4.4 Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.4.5 Cellino Biotech Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Details
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Cardiovascular Diseases Stem Cell Therapy Introduction
11.5.4 Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.5.5 Mesoblast Recent Development
11.6 BioCardia
11.6.1 BioCardia Company Details
11.6.2 BioCardia Business Overview
11.6.3 BioCardia Cardiovascular Diseases Stem Cell Therapy Introduction
11.6.4 BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.6.5 BioCardia Recent Development
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Details
11.7.2 Cedars-Sinai Business Overview
11.7.3 Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Introduction
11.7.4 Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.7.5 Cedars-Sinai Recent Development
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Details
11.8.2 Stem Cells Transplant Institute Business Overview
11.8.3 Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Introduction
11.8.4 Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.8.5 Stem Cells Transplant Institute Recent Development
11.9 CCTRN
11.9.1 CCTRN Company Details
11.9.2 CCTRN Business Overview
11.9.3 CCTRN Cardiovascular Diseases Stem Cell Therapy Introduction
11.9.4 CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.9.5 CCTRN Recent Development
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Details
11.10.2 Help Therapeutics Co., Ltd. Business Overview
11.10.3 Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Introduction
11.10.4 Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.10.5 Help Therapeutics Co., Ltd. Recent Development
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Details
11.11.2 Beijing Cellapy biotechnology Co., LTD Business Overview
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Introduction
11.11.4 Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.11.5 Beijing Cellapy biotechnology Co., LTD Recent Development
11.12 CardioCell
11.12.1 CardioCell Company Details
11.12.2 CardioCell Business Overview
11.12.3 CardioCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.12.4 CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.12.5 CardioCell Recent Development
11.13 Heartseed
11.13.1 Heartseed Company Details
11.13.2 Heartseed Business Overview
11.13.3 Heartseed Cardiovascular Diseases Stem Cell Therapy Introduction
11.13.4 Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.13.5 Heartseed Recent Development
11.14 EmCell
11.14.1 EmCell Company Details
11.14.2 EmCell Business Overview
11.14.3 EmCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.14.4 EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.14.5 EmCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Cardiovascular Diseases Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Cardiovascular Diseases Stem Cell Therapy Growth Trends by Region
2.2.1 Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Cardiovascular Diseases Stem Cell Therapy Market Dynamics
2.3.1 Cardiovascular Diseases Stem Cell Therapy Industry Trends
2.3.2 Cardiovascular Diseases Stem Cell Therapy Market Drivers
2.3.3 Cardiovascular Diseases Stem Cell Therapy Market Challenges
2.3.4 Cardiovascular Diseases Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue
3.1.1 Global Top Cardiovascular Diseases Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Cardiovascular Diseases Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cardiovascular Diseases Stem Cell Therapy Revenue
3.4 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Cardiovascular Diseases Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Diseases Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Cardiovascular Diseases Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Product and Application
3.7 Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Type
4.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Cardiovascular Diseases Stem Cell Therapy Breakdown Data by Application
5.1 Global Cardiovascular Diseases Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
6.2 North America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmicell
11.1.1 Pharmicell Company Details
11.1.2 Pharmicell Business Overview
11.1.3 Pharmicell Cardiovascular Diseases Stem Cell Therapy Introduction
11.1.4 Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.1.5 Pharmicell Recent Development
11.2 Gencell
11.2.1 Gencell Company Details
11.2.2 Gencell Business Overview
11.2.3 Gencell Cardiovascular Diseases Stem Cell Therapy Introduction
11.2.4 Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.2.5 Gencell Recent Development
11.3 BlueRock Therapeutics
11.3.1 BlueRock Therapeutics Company Details
11.3.2 BlueRock Therapeutics Business Overview
11.3.3 BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Introduction
11.3.4 BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.3.5 BlueRock Therapeutics Recent Development
11.4 Cellino Biotech
11.4.1 Cellino Biotech Company Details
11.4.2 Cellino Biotech Business Overview
11.4.3 Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Introduction
11.4.4 Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.4.5 Cellino Biotech Recent Development
11.5 Mesoblast
11.5.1 Mesoblast Company Details
11.5.2 Mesoblast Business Overview
11.5.3 Mesoblast Cardiovascular Diseases Stem Cell Therapy Introduction
11.5.4 Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.5.5 Mesoblast Recent Development
11.6 BioCardia
11.6.1 BioCardia Company Details
11.6.2 BioCardia Business Overview
11.6.3 BioCardia Cardiovascular Diseases Stem Cell Therapy Introduction
11.6.4 BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.6.5 BioCardia Recent Development
11.7 Cedars-Sinai
11.7.1 Cedars-Sinai Company Details
11.7.2 Cedars-Sinai Business Overview
11.7.3 Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Introduction
11.7.4 Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.7.5 Cedars-Sinai Recent Development
11.8 Stem Cells Transplant Institute
11.8.1 Stem Cells Transplant Institute Company Details
11.8.2 Stem Cells Transplant Institute Business Overview
11.8.3 Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Introduction
11.8.4 Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.8.5 Stem Cells Transplant Institute Recent Development
11.9 CCTRN
11.9.1 CCTRN Company Details
11.9.2 CCTRN Business Overview
11.9.3 CCTRN Cardiovascular Diseases Stem Cell Therapy Introduction
11.9.4 CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.9.5 CCTRN Recent Development
11.10 Help Therapeutics Co., Ltd.
11.10.1 Help Therapeutics Co., Ltd. Company Details
11.10.2 Help Therapeutics Co., Ltd. Business Overview
11.10.3 Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Introduction
11.10.4 Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.10.5 Help Therapeutics Co., Ltd. Recent Development
11.11 Beijing Cellapy biotechnology Co., LTD
11.11.1 Beijing Cellapy biotechnology Co., LTD Company Details
11.11.2 Beijing Cellapy biotechnology Co., LTD Business Overview
11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Introduction
11.11.4 Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.11.5 Beijing Cellapy biotechnology Co., LTD Recent Development
11.12 CardioCell
11.12.1 CardioCell Company Details
11.12.2 CardioCell Business Overview
11.12.3 CardioCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.12.4 CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.12.5 CardioCell Recent Development
11.13 Heartseed
11.13.1 Heartseed Company Details
11.13.2 Heartseed Business Overview
11.13.3 Heartseed Cardiovascular Diseases Stem Cell Therapy Introduction
11.13.4 Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.13.5 Heartseed Recent Development
11.14 EmCell
11.14.1 EmCell Company Details
11.14.2 EmCell Business Overview
11.14.3 EmCell Cardiovascular Diseases Stem Cell Therapy Introduction
11.14.4 EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
11.14.5 EmCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2026-2031)
Table 10. Cardiovascular Diseases Stem Cell Therapy Market Trends
Table 11. Cardiovascular Diseases Stem Cell Therapy Market Drivers
Table 12. Cardiovascular Diseases Stem Cell Therapy Market Challenges
Table 13. Cardiovascular Diseases Stem Cell Therapy Market Restraints
Table 14. Global Cardiovascular Diseases Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Cardiovascular Diseases Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Diseases Stem Cell Therapy as of 2024)
Table 17. Ranking of Global Top Cardiovascular Diseases Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Product and Application
Table 21. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pharmicell Company Details
Table 47. Pharmicell Business Overview
Table 48. Pharmicell Cardiovascular Diseases Stem Cell Therapy Product
Table 49. Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Pharmicell Recent Development
Table 51. Gencell Company Details
Table 52. Gencell Business Overview
Table 53. Gencell Cardiovascular Diseases Stem Cell Therapy Product
Table 54. Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Gencell Recent Development
Table 56. BlueRock Therapeutics Company Details
Table 57. BlueRock Therapeutics Business Overview
Table 58. BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Product
Table 59. BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. BlueRock Therapeutics Recent Development
Table 61. Cellino Biotech Company Details
Table 62. Cellino Biotech Business Overview
Table 63. Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Product
Table 64. Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Cellino Biotech Recent Development
Table 66. Mesoblast Company Details
Table 67. Mesoblast Business Overview
Table 68. Mesoblast Cardiovascular Diseases Stem Cell Therapy Product
Table 69. Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Mesoblast Recent Development
Table 71. BioCardia Company Details
Table 72. BioCardia Business Overview
Table 73. BioCardia Cardiovascular Diseases Stem Cell Therapy Product
Table 74. BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. BioCardia Recent Development
Table 76. Cedars-Sinai Company Details
Table 77. Cedars-Sinai Business Overview
Table 78. Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Product
Table 79. Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Cedars-Sinai Recent Development
Table 81. Stem Cells Transplant Institute Company Details
Table 82. Stem Cells Transplant Institute Business Overview
Table 83. Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Product
Table 84. Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Stem Cells Transplant Institute Recent Development
Table 86. CCTRN Company Details
Table 87. CCTRN Business Overview
Table 88. CCTRN Cardiovascular Diseases Stem Cell Therapy Product
Table 89. CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. CCTRN Recent Development
Table 91. Help Therapeutics Co., Ltd. Company Details
Table 92. Help Therapeutics Co., Ltd. Business Overview
Table 93. Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Product
Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Help Therapeutics Co., Ltd. Recent Development
Table 96. Beijing Cellapy biotechnology Co., LTD Company Details
Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview
Table 98. Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Product
Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development
Table 101. CardioCell Company Details
Table 102. CardioCell Business Overview
Table 103. CardioCell Cardiovascular Diseases Stem Cell Therapy Product
Table 104. CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. CardioCell Recent Development
Table 106. Heartseed Company Details
Table 107. Heartseed Business Overview
Table 108. Heartseed Cardiovascular Diseases Stem Cell Therapy Product
Table 109. Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. Heartseed Recent Development
Table 111. EmCell Company Details
Table 112. EmCell Business Overview
Table 113. EmCell Cardiovascular Diseases Stem Cell Therapy Product
Table 114. EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 115. EmCell Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cardiovascular Diseases Stem Cell Therapy Picture
Figure 2. Global Cardiovascular Diseases Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Autologous Features
Figure 5. Allogeneic Features
Figure 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Preclinical Case Studies
Figure 9. Clinical Phase 1,2 Case Studies
Figure 10. Cardiovascular Diseases Stem Cell Therapy Report Years Considered
Figure 11. Global Cardiovascular Diseases Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cardiovascular Diseases Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region: 2024 VS 2031
Figure 14. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players in 2024
Figure 15. Global Top Cardiovascular Diseases Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Diseases Stem Cell Therapy as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue in 2024
Figure 17. North America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 19. United States Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 23. Germany Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2020-2031)
Figure 31. China Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 39. Mexico Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 43. Turkey Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Pharmicell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 47. Gencell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 49. Cellino Biotech Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 50. Mesoblast Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 51. BioCardia Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 54. CCTRN Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 57. CardioCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 58. Heartseed Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 59. EmCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Cardiovascular Diseases Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2026-2031)
Table 10. Cardiovascular Diseases Stem Cell Therapy Market Trends
Table 11. Cardiovascular Diseases Stem Cell Therapy Market Drivers
Table 12. Cardiovascular Diseases Stem Cell Therapy Market Challenges
Table 13. Cardiovascular Diseases Stem Cell Therapy Market Restraints
Table 14. Global Cardiovascular Diseases Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Cardiovascular Diseases Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Diseases Stem Cell Therapy as of 2024)
Table 17. Ranking of Global Top Cardiovascular Diseases Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Product and Application
Table 21. Global Key Players of Cardiovascular Diseases Stem Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Cardiovascular Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cardiovascular Diseases Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pharmicell Company Details
Table 47. Pharmicell Business Overview
Table 48. Pharmicell Cardiovascular Diseases Stem Cell Therapy Product
Table 49. Pharmicell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Pharmicell Recent Development
Table 51. Gencell Company Details
Table 52. Gencell Business Overview
Table 53. Gencell Cardiovascular Diseases Stem Cell Therapy Product
Table 54. Gencell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Gencell Recent Development
Table 56. BlueRock Therapeutics Company Details
Table 57. BlueRock Therapeutics Business Overview
Table 58. BlueRock Therapeutics Cardiovascular Diseases Stem Cell Therapy Product
Table 59. BlueRock Therapeutics Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. BlueRock Therapeutics Recent Development
Table 61. Cellino Biotech Company Details
Table 62. Cellino Biotech Business Overview
Table 63. Cellino Biotech Cardiovascular Diseases Stem Cell Therapy Product
Table 64. Cellino Biotech Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Cellino Biotech Recent Development
Table 66. Mesoblast Company Details
Table 67. Mesoblast Business Overview
Table 68. Mesoblast Cardiovascular Diseases Stem Cell Therapy Product
Table 69. Mesoblast Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Mesoblast Recent Development
Table 71. BioCardia Company Details
Table 72. BioCardia Business Overview
Table 73. BioCardia Cardiovascular Diseases Stem Cell Therapy Product
Table 74. BioCardia Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. BioCardia Recent Development
Table 76. Cedars-Sinai Company Details
Table 77. Cedars-Sinai Business Overview
Table 78. Cedars-Sinai Cardiovascular Diseases Stem Cell Therapy Product
Table 79. Cedars-Sinai Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. Cedars-Sinai Recent Development
Table 81. Stem Cells Transplant Institute Company Details
Table 82. Stem Cells Transplant Institute Business Overview
Table 83. Stem Cells Transplant Institute Cardiovascular Diseases Stem Cell Therapy Product
Table 84. Stem Cells Transplant Institute Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Stem Cells Transplant Institute Recent Development
Table 86. CCTRN Company Details
Table 87. CCTRN Business Overview
Table 88. CCTRN Cardiovascular Diseases Stem Cell Therapy Product
Table 89. CCTRN Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. CCTRN Recent Development
Table 91. Help Therapeutics Co., Ltd. Company Details
Table 92. Help Therapeutics Co., Ltd. Business Overview
Table 93. Help Therapeutics Co., Ltd. Cardiovascular Diseases Stem Cell Therapy Product
Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. Help Therapeutics Co., Ltd. Recent Development
Table 96. Beijing Cellapy biotechnology Co., LTD Company Details
Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview
Table 98. Beijing Cellapy biotechnology Co., LTD Cardiovascular Diseases Stem Cell Therapy Product
Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development
Table 101. CardioCell Company Details
Table 102. CardioCell Business Overview
Table 103. CardioCell Cardiovascular Diseases Stem Cell Therapy Product
Table 104. CardioCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. CardioCell Recent Development
Table 106. Heartseed Company Details
Table 107. Heartseed Business Overview
Table 108. Heartseed Cardiovascular Diseases Stem Cell Therapy Product
Table 109. Heartseed Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. Heartseed Recent Development
Table 111. EmCell Company Details
Table 112. EmCell Business Overview
Table 113. EmCell Cardiovascular Diseases Stem Cell Therapy Product
Table 114. EmCell Revenue in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 115. EmCell Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Cardiovascular Diseases Stem Cell Therapy Picture
Figure 2. Global Cardiovascular Diseases Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Autologous Features
Figure 5. Allogeneic Features
Figure 6. Global Cardiovascular Diseases Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Preclinical Case Studies
Figure 9. Clinical Phase 1,2 Case Studies
Figure 10. Cardiovascular Diseases Stem Cell Therapy Report Years Considered
Figure 11. Global Cardiovascular Diseases Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cardiovascular Diseases Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Region: 2024 VS 2031
Figure 14. Global Cardiovascular Diseases Stem Cell Therapy Market Share by Players in 2024
Figure 15. Global Top Cardiovascular Diseases Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Diseases Stem Cell Therapy as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Cardiovascular Diseases Stem Cell Therapy Revenue in 2024
Figure 17. North America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 19. United States Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 23. Germany Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cardiovascular Diseases Stem Cell Therapy Market Share by Region (2020-2031)
Figure 31. China Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 39. Mexico Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cardiovascular Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 43. Turkey Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Cardiovascular Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Pharmicell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 47. Gencell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 49. Cellino Biotech Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 50. Mesoblast Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 51. BioCardia Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 54. CCTRN Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 57. CardioCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 58. Heartseed Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 59. EmCell Revenue Growth Rate in Cardiovascular Diseases Stem Cell Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232